These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 31362807)

  • 21. Alcoholic liver disease confers a worse prognosis than HCV infection and non-alcoholic fatty liver disease among patients with cirrhosis: An observational study.
    Marot A; Henrion J; Knebel JF; Moreno C; Deltenre P
    PLoS One; 2017; 12(10):e0186715. PubMed ID: 29077714
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Combination of racial/ethnic and etiology/disease-specific factors is associated with lower survival following liver transplantation in African Americans: an analysis from UNOS/OPTN database.
    Wong RJ; Ahmed A
    Clin Transplant; 2014 Jul; 28(7):755-61. PubMed ID: 24750171
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tailored screening and dedicated funding for direct acting antiviral drugs: how to keep Italy on the road to hepatitis C virus elimination?
    Kondili LA; Blach S; Razavi H; Craxì A
    Ann Ist Super Sanita; 2020; 56(3):325-329. PubMed ID: 32959798
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Epidemiology of hepatitis C virus infection.
    Roudot-Thoraval F
    Clin Res Hepatol Gastroenterol; 2021 May; 45(3):101596. PubMed ID: 33610022
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment of HCV reduces viral hepatitis-associated liver-related mortality in patients: An ERCHIVES study.
    Butt AA; Yan P; Shaikh OS; Lo Re V; Abou-Samra AB; Sherman KE
    J Hepatol; 2020 Aug; 73(2):277-284. PubMed ID: 32145260
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The growing contribution of hepatitis C virus infection to liver-related mortality in Scotland.
    McDonald SA; Hutchinson SJ; Bird SM; Robertson C; Mills PR; Graham L; Dillon JF; Goldberg DJ
    Euro Surveill; 2010 May; 15(18):. PubMed ID: 20460092
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mortality associated with hepatitis C and hepatitis B virus infection: A nationwide study on multiple causes of death data.
    Fedeli U; Grande E; Grippo F; Frova L
    World J Gastroenterol; 2017 Mar; 23(10):1866-1871. PubMed ID: 28348493
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hepatitis C virus testing, liver disease assessment and treatment uptake among people who inject drugs pre- and post-universal access to direct-acting antiviral treatment in Australia: The LiveRLife study.
    Bajis S; Grebely J; Hajarizadeh B; Applegate T; Marshall AD; Ellen Harrod M; Byrne J; Bath N; Read P; Edwards M; Gorton C; Hayllar J; Cock V; Peterson S; Thomson C; Weltman M; Jefferies M; Wood W; Haber P; Ezard N; Martinello M; Maher L; Dore GJ;
    J Viral Hepat; 2020 Mar; 27(3):281-293. PubMed ID: 31698545
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mortality among Alaska Native Adults with Confirmed Hepatitis C Virus Infection Compared with the General Population in Alaska, 1995-2016.
    Bressler SS; Bruden D; Nolen LD; Bruce MG; Towshend-Bulson L; Spradling P; McMahon BJ
    Can J Gastroenterol Hepatol; 2022; 2022():2573545. PubMed ID: 35178364
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Planning the hepatitis C virus elimination in Cyprus: A modeling study.
    Gountas I; Yiasemi I; Kyprianou E; Mina C; Georgiou C; Katsioloudes P; Kouroufexi A; Demetriou A; Xenofontos E; Nikolopoulos G
    World J Gastroenterol; 2021 Aug; 27(31):5219-5231. PubMed ID: 34497446
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The prevalence of alcohol-induced liver disease and hepatitis C and their interaction in a tertiary care setting.
    Said A; Williams J; Holden J; Remington P; Musat A; Lucey MR
    Clin Gastroenterol Hepatol; 2004 Oct; 2(10):928-34. PubMed ID: 15476157
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Liver function tests in primary care provide a key opportunity to diagnose and engage patients with hepatitis C.
    McLeod A; Hutchinson SJ; Weir A; Barclay S; Schofield J; Frew CG; Goldberg DJ; Heydtmann M; Wilson-Davies E
    Epidemiol Infect; 2022 Jun; 150():e133. PubMed ID: 35757860
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Forecasting Hepatitis C liver disease burden on real-life data. Does the hidden iceberg matter to reach the elimination goals?
    Kondili LA; Robbins S; Blach S; Gamkrelidze I; Zignego AL; Brunetto MR; Raimondo G; Taliani G; Iannone A; Russo FP; Santantonio TA; Zuin M; Chessa L; Blanc P; Puoti M; Vinci M; Erne EM; Strazzabosco M; Massari M; Lampertico P; Rumi MG; Federico A; Orlandini A; Ciancio A; Borgia G; Andreone P; Caporaso N; Persico M; Ieluzzi D; Madonia S; Gori A; Gasbarrini A; Coppola C; Brancaccio G; Andriulli A; Quaranta MG; Montilla S; Razavi H; Melazzini M; Vella S; Craxì A;
    Liver Int; 2018 Dec; 38(12):2190-2198. PubMed ID: 29900654
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Universal screening for hepatitis C - in for a penny, in for a pound.
    Garrido I; Macedo G
    Eur J Clin Microbiol Infect Dis; 2022 Mar; 41(3):341-347. PubMed ID: 35022892
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hepatitis C virus (HCV) infection and liver-related mortality: a population-based cohort study in southern Italy. The Association for the Study of Liver Disease in Puglia.
    Osella AR; Misciagna G; Guerra VM; Chiloiro M; Cuppone R; Cavallini A; Di Leo A
    Int J Epidemiol; 2000 Oct; 29(5):922-7. PubMed ID: 11034979
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact on mortality of being seropositive for hepatitis C virus antibodies among blood donors in Brazil: A twenty-year study.
    Filho HRM; Bierrenbach ALS; Capuani MLD; Mendrone A; Benzaken AS; Machado SM; Saivish MV; Sabino EC; Witkin SS; Mendes-Corrêa MC
    PLoS One; 2019; 14(12):e0226566. PubMed ID: 31856222
    [TBL] [Abstract][Full Text] [Related]  

  • 37. HBV infection is associated with greater mortality in hospitalised patients compared to HCV infection or alcoholic liver disease.
    Rajbhandari R; Danford CJ; Chung RT; Ananthakrishnan AN
    Aliment Pharmacol Ther; 2015 May; 41(10):928-38. PubMed ID: 25786514
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Economic evaluation of the hepatitis C elimination strategy in Greece in the era of affordable direct-acting antivirals.
    Gountas I; Sypsa V; Papatheodoridis G; Souliotis K; Athanasakis K; Razavi H; Hatzakis A
    World J Gastroenterol; 2019 Mar; 25(11):1327-1340. PubMed ID: 30918426
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Liver disease as a major cause of death among HIV infected patients: role of hepatitis C and B viruses and alcohol.
    Salmon-Ceron D; Lewden C; Morlat P; Bévilacqua S; Jougla E; Bonnet F; Héripret L; Costagliola D; May T; Chêne G;
    J Hepatol; 2005 Jun; 42(6):799-805. PubMed ID: 15973779
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Incidence of hospitalization for infection among patients with hepatitis B or C virus infection without cirrhosis in Taiwan: A cohort study.
    Lee YC; Wang JL; Dong YH; Chen HC; Wu LC; Chang CH
    PLoS Med; 2019 Sep; 16(9):e1002894. PubMed ID: 31518344
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.